{
  "trial_id": "NCT01155284",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes diagnosis, presence of diabetes-related autoantibodies, ability to swallow study capsules, compliance with intensive diabetes management, compliance with study visits and protocol, use of GLP-1R agonist or DPP-4 inhibitor, use of PPI, use of oral hypoglycemic agent, use of thiazolidinediones, renal function (GFR), history of hypersensitivity to study drugs, hepatic function, history of pancreatitis or gallbladder disease, significant medical conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Days Post diagnosis",
          "duration of diabetes diagnosis"
        ],
        [
          "GAD antibody positive",
          "presence of diabetes-related autoantibodies"
        ],
        [
          "2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test",
          "2 Hour C-peptide AUC in Response to MMTT"
        ],
        [
          "Renal insufficiency, defined as estimated glomerular filtration rate (GFR) less than 50 mL/min at Screening, calculated using the Modification of Diet in Renal Disease (MDRD) equation.",
          "renal function (GFR)"
        ],
        [
          "History of a serious hypersensitivity reaction to sitagliptin or lansoprazole, such as anaphylaxis or angioedema.",
          "history of hypersensitivity to study drugs"
        ],
        [
          "Severe hepatic insufficiency.",
          "hepatic function"
        ],
        [
          "History of pancreatitis or gallbladder disease",
          "history of pancreatitis or gallbladder disease"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "HLA DR Allele - Neither DR3 nor DR4",
        "HLA DR Allele - DR3 only",
        "HLA DR4 Allele only",
        "HLA DR Allele - Both DR3 and DR4",
        "Insulin use (units/kg per day)",
        "Glucose (mmol/L)",
        "HbA1c (%)",
        "IDA-HbA1c (%)"
      ],
      "remaining_candidate_features": [
        "ability to swallow study capsules",
        "compliance with intensive diabetes management",
        "compliance with study visits and protocol",
        "use of GLP-1R agonist or DPP-4 inhibitor",
        "use of PPI",
        "use of oral hypoglycemic agent",
        "use of thiazolidinediones",
        "significant medical conditions."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Blood Pressure, C-peptide levels, Diabetes-related autoantibodies,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Days Post diagnosis",
          "Duration of Diabetes"
        ],
        [
          "2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test",
          "C-peptide levels"
        ],
        [
          "HbA1c (%)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "GAD antibody positive",
        "HLA DR Allele - Neither DR3 nor DR4",
        "HLA DR Allele - DR3 only",
        "HLA DR4 Allele only",
        "HLA DR Allele - Both DR3 and DR4",
        "Insulin use (units/kg per day)",
        "Glucose (mmol/L)",
        "IDA-HbA1c (%)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Blood Pressure",
        "Diabetes-related autoantibodies"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Duration, BMI, HbA1c, Insulin Dose, Autoantibody Status, C-peptide AUC at Baseline,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Days Post diagnosis",
          "Diabetes Duration"
        ],
        [
          "GAD antibody positive",
          "Autoantibody Status"
        ],
        [
          "2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test",
          "C-peptide AUC at Baseline"
        ],
        [
          "HbA1c (%)",
          "HbA1c"
        ],
        [
          "Insulin use (units/kg per day)",
          "Insulin Dose"
        ]
      ],
      "remaining_reference_features": [
        "HLA DR Allele - Neither DR3 nor DR4",
        "HLA DR Allele - DR3 only",
        "HLA DR4 Allele only",
        "HLA DR Allele - Both DR3 and DR4",
        "Glucose (mmol/L)",
        "IDA-HbA1c (%)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "BMI"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of diabetes, presence of diabetes-related autoantibodies (GAD, IA-2, insulin), HbA1c, fasting C-peptide, estimated glomerular filtration rate (eGFR), history of pancreatitis or gallbladder disease, history of hypersensitivity reaction to sitagliptin or lansoprazole.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Days Post diagnosis",
          "duration of diabetes"
        ],
        [
          "GAD antibody positive",
          "presence of diabetes-related autoantibodies (GAD, IA-2, insulin)"
        ],
        [
          "HbA1c (%)",
          "HbA1c"
        ],
        [
          "2 -hour C-peptide Area Under Curve Result in Response to Standardized Mixed Meal Tolerance Test",
          "fasting C-peptide"
        ],
        [
          "estimated glomerular filtration rate (eGFR)",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "history of pancreatitis or gallbladder disease",
          "history of pancreatitis or gallbladder disease"
        ],
        [
          "history of hypersensitivity reaction to sitagliptin or lansoprazole",
          "history of hypersensitivity reaction to sitagliptin or lansoprazole"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "HLA DR Allele - Neither DR3 nor DR4",
        "HLA DR Allele - DR3 only",
        "HLA DR4 Allele only",
        "HLA DR Allele - Both DR3 and DR4",
        "Insulin use (units/kg per day)",
        "Glucose (mmol/L)",
        "IDA-HbA1c (%)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)"
      ]
    }
  }
}